Previous Section
Clinical Trials
91. First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer: a phase II study.
- Author
- Niho S; Kubota K; Goto K; Yoh K; Ohmatsu H; Kakinuma R; Saijo N; Nishiwaki Y;
- Institution
- Division of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan. siniho@east.ncc.go.jp
- Journal
- J Clin Oncol. 2006 Jan 1;24(1):64-9.
- Abstract URL
- Click here to view abstract
92. Randomized Phase II study of two opposite administration sequences of irinotecan and cisplatin in patients with advanced nonsmall cell lung carcinoma.
- Author
- Han JY; Lim HS; Lee DH; Ju SY; Lee SY; Kim HY; Park YH; Park CG; Lee JS;
- Institution
- Research Institute and Hospital, Center for Lung Cancer, National Cancer Center, Goyang, Korea.
- Journal
- Cancer. 2006 Feb 15;106(4):873-80.
- Abstract URL
- Click here to view abstract
93. Multimodality treatment of unresectable stage III non-small cell lung cancer: interim analysis of a phase II trial with preoperative gemcitabine and concurrent radiotherapy.
- Author
- Galetta D; Cesario A; Margaritora S; Porziella V; Piraino A; D'Angelillo RM; Gambacorta MA; Ramella S; Trodella L; Valente S; Corbo GM; Macis G; Mule A; Cardaci V; Sterzi S; Granone P; Russo P;
- Institution
- Department of Thoracic Surgery, European Institute of Oncology, Milan, Italy.
- Journal
- J Thorac Cardiovasc Surg. 2006 Feb;131(2):314-21. Epub 2006 Jan 18.
- Abstract URL
- Click here to view abstract
94. Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study.
- Author
- Paccagnella A; Oniga F; Bearz A; Favaretto A; Clerici M; Barbieri F; Riccardi A; Chella A; Tirelli U; Ceresoli G; Tumolo S; Ridolfi R; Biason R; Nicoletto MO; Belloni P; Veglia F; Ghi MG;
- Institution
- Medical Oncology Department, SS Giovanni and Paolo Hospital, Venezia, Italy. adriano.paccagnella@ulss12.ve.it
- Journal
- J Clin Oncol. 2006 Feb 1;24(4):681-7.
- Abstract URL
- Click here to view abstract
95. Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small-cell lung cancer.
- Author
- Yasuda H; Yamaya M; Nakayama K; Sasaki T; Ebihara S; Kanda A; Asada M; Inoue D; Suzuki T; Okazaki T; Takahashi H; Yoshida M; Kaneta T; Ishizawa K; Yamanda S; Tomita N; Yamasaki M; Kikuchi A; Kubo H; Sasaki H;
- Institution
- Department of Geriatric and Respiratory Medicine, Tohoku University School of Medicine, Seiryo-machi, Aoba-ku, Sendai, Japan. yasuda@geriat.med.tohoku.ac.jp
- Journal
- J Clin Oncol. 2006 Feb 1;24(4):688-94.
- Abstract URL
- Click here to view abstract
96. Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21.
- Author
- Bezjak A; Tu D; Seymour L; Clark G; Trajkovic A; Zukin M; Ayoub J; Lago S; de Albuquerque Ribeiro R; Gerogianni A; Cyjon A; Noble J; Laberge F; Chan RT; Fenton D; von Pawel J; Reck M; Shepherd FA;
- Institution
- Princess Margaret Hospital/University Health Network, University of Toronto, Toronto, Ontario, Canada. andrea.bezjak@rmp.uhn.on.ca
- Journal
- J Clin Oncol. 2006 Aug 20;24(24):3831-7.
- Abstract URL
- Click here to view abstract
97. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial.
- Author
- Douillard JY; Rosell R; De Lena M; Carpagnano F; Ramlau R; Gonzales-Larriba JL; Grodzki T; Pereira JR; Le Groumellec A; Lorusso V; Clary C; Torres AJ; Dahabreh J; Souquet PJ; Astudillo J; Fournel P; Artal-Cortes A; Jassem J; Koubkova L; His P; Riggi M; Hurteloup P;
- Institution
- Centre Rene Gauducheau, Nantes, France. jy-douillard@nantes.fnclcc.fr
- Journal
- Lancet Oncol. 2006 Sep;7(9):719-27.
- Abstract URL
- Click here to view abstract
98. Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer.
- Author
- Nemunaitis J; Dillman RO; Schwarzenberger PO; Senzer N; Cunningham C; Cutler J; Tong A; Kumar P; Pappen B; Hamilton C; DeVol E; Maples PB; Liu L; Chamberlin T; Shawler DL; Fakhrai H;
- Institution
- Mary Crowley Medical Research Center/Texas Oncology Professional Association, Dallas, TX, USA. jnemunaitis@mcmrc.com
- Journal
- J Clin Oncol. 2006 Oct 10;24(29):4721-30. Epub 2006 Sep 11.
- Abstract URL
- Click here to view abstract
99. Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancer.
- Author
- White SC; Lorigan P; Margison GP; Margison JM; Martin F; Thatcher N; Anderson H; Ranson M;
- Institution
- Christie Hospital NHS Trust, Manchester, UK. shane.white@austin.org.au
- Journal
- Br J Cancer. 2006 Oct 9;95(7):822-8. Epub 2006 Sep 12.
- Abstract URL
- Click here to view abstract
100. Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: study CTRT99/97 by the Bronchial Carcinoma Therapy Group.
- Author
- Huber RM; Flentje M; Schmidt M; Pollinger B; Gosse H; Willner J; Ulm K;
- Institution
- Pneumologie, Medizinische Klinik Innenstadt, and Strahlentherapie, University of Munich, Germany. huber@med.uni-muenchen.de
- Journal
- J Clin Oncol. 2006 Sep 20;24(27):4397-404.
- Abstract URL
- Click here to view abstract
Next: Radiation Therapy
